Consistently, loss of function mouse models demonstrated that DNMT3a, DNMT3b, and TET2 are tumor suppressors in a variety of hematologic malignancies including T- and B–cell lymphomas [17,18,19,20,21,22,23]. The gene discussed is DNMT3B; the disease is neoplasm.